Development of a membrane-Anchored chemerin receptor agonist as a novel modulator of allergic airway inflammation and neuropathic pain

Journal of Biological Chemistry

Volumn 289, Issue 19, 2014, Pages 13385-13396

  Doyle, Jamie R ^a   Krishnaji, Subrahmanian T ^b   Zhu, Guangli ^c   Xu, Zhen Zhong ^d,e   Heller, Daniel ^a   Ji, Ru Rong ^d,e   Levy, Bruce D ^c   Kumar, Krishna ^b   Kopin, Alan S ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Department of Anesthesiology ^*  (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; AMINO ACIDS; HEALTH; LIGANDS; MAMMALS; PEPTIDES;

AIRWAY INFLAMMATION; DORSAL ROOT GANGLIA; G PROTEIN COUPLED RECEPTORS; INFLAMMATORY DISEASE; LINKER SEQUENCE; MEMBRANE ANCHORING; NEUROPATHIC PAIN; TRANS-MEMBRANE DOMAINS;

MEMBRANE TECHNOLOGY;

CHEMERIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ALLERGIC AIRWAY INFLAMMATION; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HALF LIFE TIME; HUMAN; HUMAN CELL; IN VIVO STUDY; LIPID MEMBRANE; LUCIFERASE ASSAY; MALE; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN TARGETING;

ALLERGY; CHEMR23; CMKLR1; DRUG SCREENING; G PROTEIN-COUPLED RECEPTORS (GPCR); INFLAMMATION; LIPIDATED PEPTIDES; MEMBRANE-TETHERED LIGANDS; PHARMACOLOGY;

ANIMALS; ASTHMA; CHEMOKINES; CHEMOTACTIC FACTORS; HEK293 CELLS; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; NEURALGIA; PEPTIDES; RECEPTORS, CHEMOKINE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84900440321     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.522680     Document Type: Article

References (40)

1. Ji, R. R., Xu, Z. Z., Strichartz, G., and Serhan, C. N. (2011) Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci. 34, 599-609
2. Xu, Z. Z., Zhang, L., Liu, T., Park, J. Y., Berta, T., Yang, R., Serhan, C. N., and Ji, R. R. (2010) Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat. Med. 16, 592-597
3. Yoshimura, T., and Oppenheim, J. J. (2011) Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2): two multifunctional receptors with unusual properties. Exp. Cell Res. 317, 674-684
4. Wittamer, V., Franssen, J. D., Vulcano, M., Mirjolet, J. F., Le Poul, E., Migeotte, I., Brézillon, S., Tyldesley, R., Blanpain, C., Detheux, M., Mantovani, A., Sozzani, S., Vassart, G., Parmentier, M., and Communi, D. (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J. Exp. Med. 198, 977-985
5. Haworth, O., Cernadas, M., Yang, R., Serhan, C. N., and Levy, B. D. (2008) Resolvin E1 regulates interleukin 23, interferon-γand lipoxin A4 to promote the resolution of allergic airway inflammation. Nat. Immunol. 9, 873-879
6. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., and Serhan, C. N. (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the ω-3 lipid mediator resolvin E1. J. Exp. Med. 201, 713-722
7. Bondue, B., Wittamer, V., and Parmentier, M. (2011) Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine Growth Factor Rev. 22, 331-338
8. Du, X. Y., and Leung, L. L. (2009) Proteolytic regulatory mechanism of chemerin bioactivity. Acta Biochim. Biophys. Sin. 41, 973-979
9. Wittamer, V., Grégoire, F., Robberecht, P., Vassart, G., Communi, D., and Parmentier, M. (2004) The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J. Biol. Chem. 279, 9956-9962
10. Choi, C., Fortin, J. P., McCarthy, Ev., Oksman, L., Kopin, A. S., and Nitabach, M. N. (2009) Cellular dissection of circadian peptide signals with genetically encoded membrane-tethered ligands. Curr. Biol. 19, 1167-1175
11. Fortin, J. P., Zhu, Y., Choi, C., Beinborn, M., Nitabach, M. N., and Kopin, A. S. (2009) Membrane-tethered ligands are effective probes for exploring class B1Gprotein-coupled receptor function. Proc. Natl. Acad. Sci. U. S. A. 106, 8049-8054
12. Harwood, B. N., Fortin, J. P., Gao, K., Chen, C., Beinborn, M., and Kopin, A. S. (2013) Membrane tethered bursicon constructs as heterodimeric modulators of the Drosophila G protein-coupled receptor rickets. Mol. Pharmacol. 83, 814-821
13. Chou, K. C., and Elrod, D. W. (1999) Prediction of membrane protein types and subcellular locations. Proteins 34, 137-153
14. Fortin, J. P., Chinnapen, D., Beinborn, M., Lencer, W., and Kopin, A. S. (2011) Discovery of dual-Action membrane-Anchored modulators of incretin receptors. PLoS One 6, e24693
15. Cash, J. L., Hart, R., Russ, A., Dixon, J. P., Colledge, W. H., Doran, J., Hendrick, A. G., Carlton, M. B., and Greaves, D. R. (2008) Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J. Exp. Med. 205, 767-775
16. Schnölzer, M., Alewood, P., Jones, A., Alewood, D., and Kent, S. B. (1992) In situ neutralization in Boc-chemistry solid phase peptide synthesis: rapid, high yield assembly of difficult sequences. Int. J. Pept. Protein Res. 40, 180-193
17. Pennington, M. W. (1994) HF cleavage and deprotection procedures for peptides synthesized using a Boc/Bzl strategy. Methods Mol. Biol. 35, 41-62
18. Gill, S. C., and Von Hippel, P. H. (1989) Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182, 319-326
19. Doyle, J. R., Lane, J. M., Beinborn, M., and Kopin, A. S. (2013) Naturally occurring HCA1 missense mutations result in loss of function: potential impact on lipid deposition. J. Lipid Res. 54, 823-830
20. Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., and Behr, J. P. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U. S. A. 92, 7297-7301
21. i. Nature 363, 274-276
22. Kostenis, E., Martini, L., Ellis, J., Waldhoer, M., Heydorn, A., Rosenkilde, M. M., Norregaard, P. K., Jorgensen, R., Whistler, J. L., and Milligan, G. (2005) A highly conserved glycine within linker I and the extreme C terminus of G protein αsubunits interact cooperatively in switching G proteincoupled receptor-to-effector specificity. J. Pharmacol. Exp. Ther 313, 78-87
23. Summerhill, S., Stroud, T., Nagendra, R., Perros-Huguet, C., and Trevethick, M. (2008) A cell-based assay to assess the persistence of action of agonists acting at recombinant human β2 adrenoceptors. J. Pharmacol. Toxicol. Methods 58, 189-197
24. Romano, R., Dufresne, M., Prost, M. C., Bali, J. P., Bayerl, T. M., and Moroder, L. (1993) Peptide hormone-membrane interactions. Intervesicular transfer of lipophilic gastrin derivatives to artificial membranes and their bioactivities. Biochim. Biophys. Acta 1145, 235-242
25. Bellucci, F., Carini, F., Catalani, C., Cucchi, P., Lecci, A., Meini, S., Patacchini, R., Quartara, L., Ricci, R., Tramontana, M., Giuliani, S., and Maggi, C. A. (2002) Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. Br. J. Pharmacol. 135, 266-274
26. Bennett, G. J., and Xie, Y. K. (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33, 87-107
27. Xu, Z. Z., Liu, X. J., Berta, T., Park, C. K., Lu, N., Serhan, C. N., and Ji, R. R. (2013) Neuroprotectin/protectin D1 protects neuropathic pain in mice after nerve trauma. Ann. Neurol. 74, 490-495
28. Xu, Z. Z., Berta, T., and Ji, R. R. (2013) Resolvin E1 inhibits neuropathic pain and spinal cord microglial activation following peripheral nerve injury. J. Neuroimmune Pharmacol. 8, 37-41
29. Flatters, S. J., and Bennett, G. J. (2004) Ethosuximide reverses paclitaxeland vincristine-induced painful peripheral neuropathy. Pain 109, 150-161
30. Shimamura, K., Matsuda, M., Miyamoto, Y., Yoshimoto, R., Seo, T., and Tokita, S. (2009) Identification of a stable chemerin analog with potent activity toward ChemR23. Peptides 30, 1529-1538
31. Luangsay, S., Wittamer, V., Bondue, B., De Henau, O., Rouger, L., Brait, M., Franssen, J. D., De Nadai, P., Huaux, F., and Parmentier, M. (2009) Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. J. Immunol. 183, 6489-6499
32. Zhang, L., and Bulaj, G. (2012) Converting peptides into drug leads by lipidation. Curr. Med. Chem. 19, 1602-1618
33. Weinstock, M. T., Francis, J. N., Redman, J. S., and Kay, M. S. (2012) Protease-resistant peptide design-empowering nature's fragile warriors against HIV. Biopolymers 98, 431-442
34. Powell, M. F., Stewart, T., Otvos, L., Jr., Urge, L., Gaeta, F. C., Sette, A., Arrhenius, T., Thomson, D., Soda, K., and Colon, S. M. (1993) Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum. Pharm. Res. 10, 1268-1273
35. Zhuang, Z. Y., Wen, Y. R., Zhang, D. R., Borsello, T., Bonny, C., Strichartz, G. R., Decosterd, I., and Ji, R. R. (2006) A peptide c-Jun. N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J. Neurosci. 26, 3551-3560
36. Jacobsen, E. A., Ochkur, S. I., Lee, N. A., and Lee, J. J. (2007) Eosinophils and asthma. Curr. Allergy Asthma Rep. 7, 18-26
37. Wegmann, M. (2011) Targeting eosinophil biology in asthma therapy. Am. J. Respir. Cell Mol. Biol. 45, 667-674
38. Albanesi, C., Scarponi, C., Pallotta, S., Daniele, R., Bosisio, D., Madonna, S., Fortugno, P., Gonzalvo-Feo, S., Franssen, J. D., Parmentier, M., De Pità, O., Girolomoni, G., and Sozzani, S. (2009) Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J. Exp. Med. 206, 249-258
39. Ernst, M. C., and Sinal, C. J. (2010) Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol. Metab. 21, 660-667
40. Ishida, T., Yoshida, M., Arita, M., Nishitani, Y., Nishiumi, S., Masuda, A., Mizuno, S., Takagawa, T., Morita, Y., Kutsumi, H., Inokuchi, H., Serhan, C. N., Blumberg, R. S., and Azuma, T. (2010) Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis. Inflamm. Bowel Dis. 16, 87-95